RiverPark Advisors’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$264K Sell
14,986
-195
-1% -$3.92K 0.1% 80
2025
Q4
$300K Buy
15,181
+305
+2% +$5.48K 0.09% 81
2025
Q3
$260K Sell
14,876
-4,248
-22% -$63K 0.11% 65
2025
Q2
$268K Sell
19,124
-799
-4% -$12.9K 0.16% 65
2025
Q1
$371K Buy
19,923
+10,512
+112% +$157K 0.29% 58
2024
Q4
$106K Buy
+9,411
New +$110K 0.08% 99

Other funds holding ALHC

RiverPark Advisors's ALHC Position: Q1 2026 in Review

RiverPark Advisors reduced its Alignment Healthcare (ALHC) stake by 1.3% in Q1 2026, selling an estimated $3.92K and leaving 14,986 shares worth $264K. The position accounts for 0.1% of the portfolio, ranked #80.

RiverPark Advisors first reported a position in ALHC in Q4 2024 and has held it in 6 quarters since. The position peaked at $371K in Q1 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • RiverPark Advisors held 14,986 shares of Alignment Healthcare worth $264K as of Q1 2026.
  • RiverPark Advisors sold 195 Alignment Healthcare shares in Q1 2026, an estimated $3.92K.
  • Alignment Healthcare made up 0.1% of RiverPark Advisors's portfolio in Q1 2026, its #80 holding.
  • RiverPark Advisors first reported a position in Alignment Healthcare in Q4 2024 and has held it in 6 quarters since.
  • RiverPark Advisors's Alignment Healthcare position peaked at $371K in Q1 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on RiverPark Advisors's 13F filing for Q1 2026, filed 14 May 2026.